K Pharma,Inc.
K Pharma,Inc. scores highest on Anchor (46) and lowest on Price (2). Its PosiPenta is 20.84 out of 100, weaker than most similar companies.
On the Penta Grid this week, K Pharma,Inc. is Grid #53 of 53 in the Healthcare sector in Japan, and Grid #1,050 of 1,059 in Japan.
Compared with similar companies in the Healthcare sector in Japan.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| K Pharma,Inc. | 20.84 | 2 | 7 | 44 | 6 | 46 |
| Koken Ltd. | 60.00 | 90 | 80 | 33 | 39 | 58 |
| Yamashita Health Care Holdings,Inc. | 65.52 | 64 | 87 | 70 | 50 | 57 |
| Create Medic Co., Ltd. | 61.79 | 67 | 53 | 79 | 51 | 59 |
| Morishita Jintan Co., Ltd. | 70.43 | 84 | 84 | 68 | 50 | 66 |
| StemRIM | 28.11 | 27 | 23 | 6 | 54 | 31 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -7.78 |
| P/B ratio | 10.49 |
EEarnings
| Trailing EPS | ₹-54.28 |
| Forward EPS | — |
NNitro
| Price | 422.54 |
| 52-week high | 574.49 |
| 52-week low | 365.64 |
| Fall from 52-week high | 26.4% |
TTorque
| Return on equity (ROE) | -80.51% |
| Debt-to-equity | 2.12 |
AAnchor
| Beta (price swings) | 0.43 |
| Market cap | ₹491 Cr |
| Insider holding | 66.01% |
| Dividend yield | 0.00% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is K Pharma,Inc.'s PosiPenta score?
K Pharma,Inc.'s PosiPenta is 20.84 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Where does K Pharma,Inc. stand on the Penta Grid?
On the Penta Grid this week, K Pharma,Inc. is Grid #53 of 53 in the Healthcare sector in Japan, and Grid #1,050 of 1,059 in Japan.
Which PosiPenta pillar is strongest for K Pharma,Inc.?
Anchor (stability and dividends), with a score of 46 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for K Pharma,Inc.?
Price (valuation), with a score of 2 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.